Latest Announcements

Sanofi India Ltd announced unaudited financial results for the quarter and half year ended 30th June 2026, with a double-digit growth of 14% in the diabetes business, driven by innovative portfolio Toujeo and Soliqua. The company maintained a market leadership position with a 47% market share by value and volume acceleration of 6% with Lantus. The results were presented during an investor conference call on August 5, 2026.

Kirloskar Brothers Ltd. has announced its unaudited financial results for Q1 FY '27, with a 13% year-on-year growth in consolidated revenue to Rs.11,049 million. The company's consolidated EBITDA for the quarter stood at Rs.1,306 million, with a 2% year-on-year growth and an EBITDA margin of 11.8%. The company also recorded a 4% year-on-year growth in consolidated order intake to Rs.13,954 million.

Alembic Pharmaceuticals Ltd reported a strong Q1 FY27 with 26% YoY revenue growth, driven by growth across all major businesses, including a 7% growth in India branded business, 37% growth in International Generics, and 33% growth in API business. The company's external environment remains competitive with pricing pressure, regulatory expectations, and geopolitical uncertainties.

Man Infraconstruction Ltd has launched Marina Vista, an ultra-luxury residential project in Pali Hill, Bandra (West), Mumbai, achieving 30% pre-sales commitment at launch.

CESC Ltd's subsidiary Purvah Green Power Private Limited acquires 100% share capital of six renewable energy companies from ReNew Solar Power Private Limited for INR 4859 crores, expanding CESC's renewable power footprint to over 1.8 GWp.

Emami Ltd reported Q1 FY27 earnings, with consolidated revenue growing 15% to INR1,039 crores, driven by 20% growth in domestic business and 12% growth on a like-to-like basis. The company is transitioning to category-wise reporting and has seen strong performance in hair and scalp care, healthcare, and strategic investment portfolio.

Lyka Labs Ltd has announced its unaudited financial results for Q1 FY27, showing a 42.67% increase in standalone net total income and a 159.04% increase in standalone net profit.

Man Infraconstruction Ltd secured the Intimation of Approval (IOA) for its ultra-luxury sea-view residential development located off Bandstand, Bandra West, Mumbai, with a Gross Development Value (GDV) of ₹1,000+ crores.

Gulf Oil Lubricants India Ltd reported Q1 FY27 earnings, with revenue crossing INR 1,300+ crores, a 30% increase from the previous quarter. EBITDA and profits also showed significant growth. The company managed to maintain supply security despite the West Asia crisis and volatile macro environment, and won new customers in various segments.

Bajel Projects Ltd has received two significant orders from Power Grid Corporation of India Ltd under the Western Region–Eastern Region (WR-ER) Inter-Regional Network Expansion Scheme, worth INR 400 Cr+ and INR 300 Cr+ respectively.

Kwality Pharmaceuticals Ltd has raised its FY27 guidance for revenue and profitability, citing strong execution and clear visibility. The company has also highlighted its expertise in complex formulation, research, and manufacturing, with a broad and diverse product offering across 25+ therapeutic areas. The announcement includes forward-looking statements and cautions against relying on them for future performance.

Kakatiya Cement Sugar & Industries Ltd declared a dividend of Rs.3.00 per share for the financial year ending 31st March, 2026, at its Annual General Meeting held on 10th August, 2026. The dividend, if approved, will be paid on or before 7th September, 2026, to shareholders whose names stand on the Register of Members and Register of Beneficial Owners as on 3rd August, 2026.

Kakatiya Cement Sugar & Industries Ltd declared a dividend of Rs.3.00 per share for the financial year ending 31st March, 2026, at its Annual General Meeting held on 10 August, 2026. The dividend, if approved, will be paid on or before 7 September, 2026.

Metro Brands Ltd reported a 14% growth in its standalone business and a 9% growth in EBITDA for Q1 FY '27, with a 13% PAT. The company saw strong sales performance from Clarks and marketing campaigns, and growth in its D2C website and marketplace omni business.

Kwality Pharmaceuticals Ltd reported a strong Q1FY27 with 46% YoY revenue growth, 13% YoY EBITDA growth, and 119% YoY PAT growth. The company raised FY27 guidance across all key metrics.

Mold-Tek Technologies Ltd's Q1 FY'27 earnings conference call transcript reveals a stellar performance with a 4x jump in profitability and 12x increase compared to Q1 last year, driven by increased revenues, operational efficiencies, and cost control. The company expects Beryl to contribute positively to the bottom line from Q3 onwards, with the design team in India executing projects for Florida clients. The company also secured a contract with a top US power distribution company and is expanding its team to meet growing demand.

Nirlon Ltd's Q1 FY 2027 earnings presentation highlights a 5.9% revenue growth, 29.9% PAT, and 73.84% ROE. The company's major shareholder, GIC Singapore, holds a 63.92% stake. Nirlon Knowledge Park (NKP) has a total chargeable area of approximately 3.08 Mn sq. ft. and is 100% occupied. The company proposes a final dividend of INR 15 per share for FY 26.

Omnitech Engineering Ltd has announced its Q1 FY27 earnings, with revenue growing 61.5% YoY to INR116 crores and PAT increasing 468.7% YoY to INR29.7 crores. The company has a robust order book of INR3,000 crores and plans to operationalize two new facilities in 14 months to expand its manufacturing capacity.

Kwality Pharmaceuticals Ltd reported a strong start to FY27 with 46% YoY revenue growth, 13% YoY EBITDA growth, and 119% YoY PAT growth. The company has raised FY27 guidance across all key metrics.

Monika Alcobev Ltd has been appointed as Remy Cointreau's exclusive partner across India, strengthening its position as the country's most trusted import, distribution, and marketing platform in the premium alcobev segment.